序号 |
标题 |
次数 |
作者 |
发布时间 |
82486 |
3-三氟甲基-6-硝基胍基[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪化合物 |
121 |
WYQ |
2024-11-29 |
82487 |
DOTA-「Tyr3」-Octreotide , DOTA-(酪氨酸3)-奥曲肽 |
83 |
wyh |
2024-11-29 |
82488 |
1,4-二吡唑基-2,3,5,6-四嗪构筑的金属有机框架 |
127 |
WYQ |
2024-11-29 |
82489 |
1,4-二-(吡唑基)-2,3,5,6-四嗪修饰三氟甲基磺酸锌[Zn(bptz)2]n |
171 |
WYQ |
2024-11-29 |
82490 |
3,6-二(4-吡啶基)-1,2,4,5-四嗪 |
88 |
WYQ |
2024-11-29 |
82491 |
DOTA-PEG4-MeTz DOTA-PEG4-甲基四嗪 甲基四嗪聚乙二醇大环化合物 |
140 |
zcy |
2024-11-29 |
82492 |
5966-29-0;N-棕榈酰-D-赤型-鞘氨醇;C16 Dihydroceramide (d18:0/16:0) |
352 |
kx |
2024-11-29 |
82493 |
p-SCN-Bn-DOTA ;2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
92 |
wyh |
2024-11-29 |
82494 |
DOTA-Suc-Lys-(FAPI-04)2 3029114-60-8 DOTA-琥珀酰基-赖氨酸-(FAPI-04)2 |
106 |
zcy |
2024-11-29 |
82495 |
913528-04-8 , DOTAM-mono-acid-CSDN |
74 |
wyh |
2024-11-29 |
82496 |
降冰片烯单体[5-降冰片烯-2-亚甲氧基-4-己氧基联苯(PhHN)] |
151 |
h |
2024-11-29 |
82497 |
Tm-DOTA , DOTA大环化合物 |
85 |
wyh |
2024-11-29 |
82498 |
四嗪基UIO-66金属有机骨架 |
266 |
WYQ |
2024-11-29 |
82499 |
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) 定制 |
107 |
zcy |
2024-11-29 |
82500 |
四嗪功能基团修饰寡聚(p-苯撑乙炔)分子 |
135 |
WYQ |
2024-11-29 |
82501 |
icariside C3,CAS号:108906-48-5 |
146 |
zyl |
2024-11-29 |
82502 |
1,2,4,5-四嗪-3,5-双(1H-1,2,4-三唑-3-硝胺基) |
122 |
WYQ |
2024-11-29 |
82503 |
DOTA-tris(acid)-amido-dPEG®11-Maleimide;DOTA-聚乙二醇(dPEG)间隔基-马来酰亚胺 |
112 |
zcy |
2024-11-29 |
82504 |
3-三氟甲基-6-氨基[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪类含能化合物 |
94 |
WYQ |
2024-11-29 |
82505 |
DOTA-(Tyr3)-Octreotate ,DOTA-3-酪氨酰基-奥曲肽 |
68 |
wyh |
2024-11-29 |
82506 |
N-(3-(三氟甲基)-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)硝酸酰胺 |
137 |
WYQ |
2024-11-29 |
82507 |
TCO-C3-PEG3-C3-amine,cas:2028288-77-7,反式环辛烯-C3-三聚乙二醇-C3-氨基 |
127 |
zyl |
2024-11-29 |
82508 |
Maleimide-DOTA-GA 马来酰亚胺-DOTA-镓 大环配体化合物 |
176 |
zcy |
2024-11-29 |
82509 |
Mem-Tz-Rh 四嗪与罗丹明结构连接溶酶体靶向探针 |
204 |
WYQ |
2024-11-29 |
82510 |
Mito-Tz-BDP Bodipy与四嗪共轭连接线粒体靶向探针 |
160 |
WYQ |
2024-11-29 |
82511 |
DOTA标记的双c(RGDfK)环肽 |
121 |
wyh |
2024-11-29 |
82512 |
3-三氟甲基-6-硝基胍基 [1,2,4]三唑并[4,3-b][1,2,4,5]四嗪化合物 |
149 |
WYQ |
2024-11-29 |
82513 |
DOTA-Ubiquicidin (29-41) acetate 基于NOTADOTA定制和偶联 |
117 |
zcy |
2024-11-29 |
82514 |
N-(3-(三氟甲基)-[1,2,4]三唑并[4,3-b] [1,2,4,5]四嗪)硝酸酰胺 |
126 |
WYQ |
2024-11-29 |
82515 |
C16-02:0 PC;CAS号:74389-68-7 |
110 |
zyl |
2024-11-29 |
82516 |
6 -氨-3-(三氟甲基)-[1,2,4]三唑[4,3-b] [1,2,4,5]四嗪 |
98 |
WYQ |
2024-11-29 |
82517 |
Cuprate(2-)-64Cu, [N-[2-[4,10-bis[(carboxy-κO)methyl]-7-(carboxymethyl)-1,4,7,10-tetraazacyclododec-1 定制 |
115 |
zcy |
2024-11-29 |
82518 |
1006711-90-5 ,DOTA-MAL , DOTA-马来酰亚胺 |
145 |
wyh |
2024-11-29 |
82519 |
6 -(3,5-二甲基吡唑)-3-(三氟甲基)-[1,2,4]三唑并[4,3-b] [1,2,4,5]四嗪 |
111 |
WYQ |
2024-11-29 |
82520 |
N-stearoyl-D-erythro-sphingosine (C17 base), powder;CAS号:123065-42-9 |
114 |
zyl |
2024-11-29 |
82521 |
DTPA-BSA-Gd , 二乙三胺五乙酸钆-牛血清白蛋白络合物 |
203 |
wyh |
2024-11-29 |
82522 |
羟基喹啉修饰降冰片烯功能化的聚合物PN2 |
111 |
h |
2024-11-29 |
82523 |
2792156-83-1 IPB-K(DOTA)-FAPI 基于NOTADOTA定制和偶联 |
136 |
zcy |
2024-11-29 |
82524 |
环氧功能化单体插入率的降冰片烯共聚物 aP(BN/MGENB)-x |
145 |
h |
2024-11-29 |
82525 |
萘酰亚胺修饰聚降冰片烯共聚物 P-NB-NA-PEG |
159 |
h |
2024-11-29 |
82526 |
CAS:909024-55-1 DOTA-cyclo(RGDfK)acetate |
86 |
zcy |
2024-11-29 |
82527 |
2192281-54-0 , PSMA IandT |
112 |
wyh |
2024-11-29 |
82528 |
5-降冰片烯-2-甲基-聚环氧丙烷 NB-PPO |
122 |
h |
2024-11-29 |
82529 |
DOTA-PEG(24)-TFP*2TFA 功能性化合物 |
102 |
zcy |
2024-11-29 |
82530 |
N'-(6-(3,5-二甲基吡唑)-1,2,4,5-四嗪)-2,2,2-三氟乙酰肼 |
111 |
WYQ |
2024-11-29 |